Thursday, June 8, 2023
DISCLOSURE OF UNLABELED USE AND INVESTIGATIONAL PRODUCTS
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLOSURE DECLARATION
It is the policy of National Lipid Association (NLA) to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. Planners, faculty, reviewers, and staff have disclosed any financial relationships with commercial interests as defined by the ACCME.
DISCLAIMER
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. The NLA specifically disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through reader’s misunderstanding of content.
PERMISSIONS
The NLA acknowledges that permissions have been obtained for use of all copyrighted materials, including graphs, tables, pictures, and charts printed in this activity syllabus. Permissions have also been obtained from identifiable patients in photographs and other images, consistent with the DHHS HIPAA regulations for individual privacy.
Adjunct Clinical Professor
University of Houston College of Pharmacy
Houston, Texas
Preventive Cardiologist and Lipidologist
Baylor Scott & White Medical Center
Plano, Texas
Medscape, LLC staff have disclosed that they have no relevant financial relationships.
Susan Halli Demeter, DNP, FNP-BC, CLS
Assistant Professor of Medicine
Heart Health & Performance Program
Lipid Clinic
Mayo Clinic Arizona
This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.
This activity is intended for cardiologists, primary care physicians, nurses, and pharmacists.
The goal of this activity is to highlight current gaps in the management of dyslipidemia and the role that access to proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors plays in managing these patients effectively, as well as to discuss collaborative care in overcoming some of the access issues with PCSK9 inhibitors.
Upon completion of this activity, participants will:
DISCLOSURE OF UNLABELED USE AND INVESTIGATIONAL PRODUCTS
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLOSURE DECLARATION
It is the policy of National Lipid Association (NLA) to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. Planners, faculty, reviewers, and staff have disclosed any financial relationships with commercial interests as defined by the ACCME.
DISCLAIMER
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. The NLA specifically disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through reader’s misunderstanding of content.
PERMISSIONS
The NLA acknowledges that permissions have been obtained for use of all copyrighted materials, including graphs, tables, pictures, and charts printed in this activity syllabus. Permissions have also been obtained from identifiable patients in photographs and other images, consistent with the DHHS HIPAA regulations for individual privacy.
Adjunct Clinical Professor
University of Houston College of Pharmacy
Houston, Texas
Preventive Cardiologist and Lipidologist
Baylor Scott & White Medical Center
Plano, Texas
Medscape, LLC staff have disclosed that they have no relevant financial relationships.
Susan Halli Demeter, DNP, FNP-BC, CLS
Assistant Professor of Medicine
Heart Health & Performance Program
Lipid Clinic
Mayo Clinic Arizona
This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.
Developed through a partnership between Medscape and National Lipid Association.
The National Lipid Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The National Lipid Association designates this enduring internet activity for a maximum of 0.25 AMA PRA Category 1 Credits TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.
The maximum number of hours awarded for this CE activity is 0.25 contact hours.
For the advanced practice nurse, this activity has 0.25 contact hours of pharmacotherapy content.
Universal Activity Number –JA0007192-9999-21-006-H01-P (Knowledge)
This Activity has been approved for 0.25 contact hour(s) (0.025 CEUs) of the Accreditation Council for Pharmacy Education.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / CE Released: 5/20/2021
Valid for credit through: 5/20/2022
processing....
A Powerpoint version of the slides from this presentation
is available for use as a professional resource from Medscape Education.
